APSC Consensus Statement on the Management of Worsening Heart Failure
Dr David Sim shares key recommendations for the management of worsening Heart Failure from the APSC Consensus Statement.
Related Links
- Navigating Cardiotoxicity: A Practical Guide to Cardiac Biomarkers during Chemotherapy
- Continuous Glucose Monitoring with AI-enabled Predictive Algorithms for Diabetes Care: Expert Views from Hong Kong
- NT-proBNP as an Effective Screening Tool for CVD in People with Diabetes
- MASH and Hepatic Fibrosis: Intersecting Metabolic Pathways
- How to Manage PMI? – Practical Implementation in Ramathibodi Hospital
- Lp(a) Screening at Least Once a Lifetime! Unwrapping the What, Why and How’s of Lipoprotein(a)
- NT-proBNP as a predictor of Cardio-renal Complications in PwD
- Safety of Rx Optimisation Post AHF Hospitalization
- Practical Implementation of GDMT Optimisation – The ATP in NZ
- Use of Rapid Algo for Suspected AMI – Faster Triage of ED Patients
- Navigating Cardiotoxicity – Value of Cardiac Biomarkers
- DROP Asian ACS – Study Results and Practical Approach
- The Importance of Early Diagnosis and Management of AHF
- Integrative Approaches to Managing Diabetes and Cardiovascular Disease
- Optimising GDMT Post AHF Discharge – APAC APSC Consensus Highlights
- Initiation of GDMT Therapy in Patients Discharged Post AHF – What are the Guardrails?
- Enhancing Diabetes and Cardiovascular Management with Continuous Glucose Monitoring
- New Frontiers for Risk Stratification Assays for Acute Coronary Syndrome – The Gen6 Assay for hs cTnT
- NT-proBNP for Rapid Optimisation of GDMT in AHF Patients in Japan
- Diabetes and Hajj: Doctor’s Awareness Program
- Diabetes and Ramadan: Public Awareness Program
- Ramadan & Diabetes
- International Speaker Program (ISP) From Diabetes to Wellbeing: A Global Dialogue on Holistic Health
- World Anaesthesia Day: Dawn of a New Era in the Management of Perioperative Myocardial Infarction (PMI)
- EMPORIUM – Full Throttle Against HF: From Detection to Protection
- Communicating the value of CVD screening in T2DM to patients
- Lipoprotein(a): The science behind the Risk Factor
- 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
- STRONG-HF: Implementation of GDMT Heart Failure Therapy & Post-discharge Heart Failure Management
- NT-proBNP and ECHO in heart failure – do they always go hand in hand?
- Rapid ACS Rule Out in Emergency Patients
- How to Implement the 0-h/1-h Algorithm to your Institute?
- High Sensitivity Cardiac Troponins and ACS – the Malaysian Experience
- APAC Heart Failure Gap Report
- Value of NT-ProBNP for Treatment Monitoring in CHF
- Role of Diagnostics: NT-proBNP in management of Heart Failure
- Taking Diabetes to Heart: Value of Cardiovascular Biomarkers for your Diabetic Patients
- Tips for implementing ESC high sensitivity cardiac troponin (hs-cTn) rapid algorithms for triage of AMI patients
- Comparing the ESC high sensitivity cardiac troponin (hs-cTn) rapid algorithms for triage of AMI patients
- Clinical Cases: Differentiating acute from chronic cardiac conditions
- Clinical Cases: Diagnostic relevance of elevated hs-cTnT
- Clinical Cases from Korea: Serial NT-proBNP measurement and Heart Failure prognosis
- Clinical Cases from Korea: NT-proBNP for Differential diagnosis of patients with dyspnoea
- Clinical Cases from Korea: Value of NT-proBNP in Cardiomyopathy
- Clinical Cases from Korea: High NT-proBNP levels useful in differential diagnosis of HF
- Dr David Sim’s Clinical Cases: NT-proBNP in Heart Failure Patients
- Clinical Cases: Elevations of hs-TnT in Non-cardiac Conditions
- Clinical Cases: hs-TnT in Patients with End Stage Renal Failure
- Clinical Cases: Serial Monitoring Differentiates Acute and Chronic hs-TnT Elevation
- Dr Lee’s Clinical Cases: hs-TnT Chronic Elevation non-AMI cases
- Dr Lee’s Clinical Cases: hs-TnT Early “Rule-In” for AMI
- FAQ: NT-proBNP Interpretation in Multiple Scenarios
- FAQ: NT-proBNP vs Cardiac Medications
- FAQ: Role of NT-proBNP in Heart Failure Management
- At the forefront of Acute Coronary Syndrome management in ED
- Serial testing of hs cTn rules out low risk of AMI
- Latest IFCC Recommendations for Natriuretic Peptides in Heart Failure – Analytics and Clinical Considerations
- Natriuretic Peptide Measurement during ARNi Treatment
- NT-proBNP in Hospital & Ambulatory Settings: Evidence to Clinical Practice
- Early triage of patients with acute chest pain with hs-TnT 0h/1h Algorithm
- Novel Biomarker-based Risk Score in AF: ABC Risk Score
- Understanding Reasons for Increased Troponin Levels
- hs-TnT Rapid Diagnosis of AMI- ESC 0h/3h Algorithm
- hs-TnT Rapid Diagnosis of AMI- ESC 0h/1h Algorithm